Renal microvascular disease is crucial to renal disease progression. Renal microvascular disease in late stage diabetic nephropathy is associated with defective angiogenesis and fails to respond to vasodilator treatment. Recognition of early renal microvascular disease is necessary, since in this stage, the vascular homeostasis is adequately functional and responsive to vasodilator treatment. Indices that can screen early renal microvascular disease include creatinine clearance or glomerular filtration rate, renal plasma flow or peritubular capillary flow and fractional excretion of magnesium (FE Mg).
INTRODUCTION
Renal microvascular disease is a progressive entity that usually remains asymptomatic, and is recognized only when the disease is associated with advanced renal insufficiency. Accumulating evidence supports the correlation between renal microvascular rarefaction and the progression of tubulointerstitial disease [1] [2] [3] . Intrarenal hemodynamic study confirms the cause-and -effect relationship that the peritubular capillary flow reduction precedes the development of tubulointerstitial fibrosis in chronic kidney disease (CKD) indicating chronic renal ischemia is the crucial mechanism of renal disease progression [4] . Treatment to correct renal ischemia with vasodilators at early CKD or early diabetic nephropathy during normoalbuminuria can enhance renal perfusion as well as restore renal function; inasmuch as the vascular homeostasis is adequately functional in this early stage. In contrast, treatment with vasodilators at late stage (CKD stages 3-5) fails to correct renal ischemia, or restore renal function which is due to the altered vascular homeostasis and an impaired nitric oxide production observed in late CKD leading to the therapeutic resistance to vasodilators [5] . It is an unfortunate event, since treatment of CKD under common practice, is usually initiated at a rather late stage due to the late recognition of CKD secondary to the insensitiveness of the available diagnostic marker such as serum creatinine determination, as well as to the improper definition of CKD defined by the National Kidney Foundation. K/DOQI guidelines [6] .
INDICES INDICATING EARLY RENAL MI-CROVASCULAR DISEASE IN DIABETES
In accordance with the preceding information, it is necessary to recognize early renal microvascular disease in order to implement the therapeutic intervention at an early stage under the environment favourable for angiogenesis and renal *Address correspondence to this author at the Renal Microcirculation Research Group, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand; Tel: 60813511214; Fax: 022584267; E-mail: fmednft@yahoo.com regeneration. Infact, early renal microvascular disease can be determined directly by intrarenal hemodynamic study. Determinations of renal plasma flow and peritubular capillary flow in a variety of patients associated with CKD or diabetes who had renal histopathologic study, have provided useful information regarding the pathogenesis of renal disease progression ( Table 1) . In this essence, renal plasma flow and peritubular capillary flow correlate inversely with the magnitude of tubulointerstitial fibrosis. It has been demonstrated that a CKD patient with a normal or mildly reduced renal perfusion does not develop tubulointerstitial fibrosis. A further reduction in renal perfusion to the level of thirty percent, induces a mild degree of tubulointerstitial fibrosis. A greater reduction in renal perfusion is associated with a higher magnitude of tubulointerstitial fibrosis [4] [5] . In this regard, recognition of early renal microvascular disease can be reflected directly by intrarenal hemodynamic study which would detect the early reduction in renal plasma flow, or peritubular capillary flow, as well as by the histopathologic study of the kidney tissue which demonstrates the presence of renal microvascular rarefaction. In accordance with the correlation between tubulointerstitial fibrosis and renal microvascular disease, tubulointerstitial fibrosis can be a diagnostic marker reflecting renal microvascular disease. When the preceding diagnostic procedures are not performed or generally unavailable, they can be reflected indirectly by the determination of fractional excretion of magnesium (FE Mg). FE Mg has been demonstrated earlier to directly correlate with the magnitude of tubulointerstitial fibrosis in a variety of chronic kidney diseases [7] . In this essence, a mild elevation of FE Mg indicates the presence of a small magnitude of tubulointerstitial fibrosis, whereas the higher elevation of FE Mg reflects the greater magnitude of tubulointerstitial firosis. In addition, FE Mg has also been demonstrated to inversely correlate with the peritubular capillary flow reduction in type 2 diabetic nephropathy [8] and idiopathic nephrotic syndrome [9, 10] .
In the absence of renal histopathologic study or intrarenal hemodynamic study, the determination of creatinine clearance can reflect the status of renal plasma flow or renal Fig. (1) . Intrarenal hemodynamics demonstrates a direct correlation between renal plasma flow and GFR. Fig. (2) . Demonstrates a direct correlation between FE Mg and CCr. microvascular disease as well as the status of chronic kidney disease, since creatinine clearance or glomerular filtration rate correlates directly with renal plasma flow ( Fig. 1) In addition to the above information, we have recently demonstrated that FE Mg is also inversely correlated with the creatinine clearance (Fig. 2) . Thus, under current practice, FE Mg and creatinine clearance would be useful diagnostic indices to identify both early renal microvascular disease and early CKD.
Recently, microalbuminuria has been recognized as a biomarker reflecting renal microvascular disease [11, 12] . Altered vascular homeostasis namely defective angiogenic factors such as vascular endothelial growth factor (VEGF), angiopoietin 1, VEGF receptor 1 and elevated antiangiogenic factors such as angiopoietin 2, VEGF receptor 2 reflects vascular disease. However, altered vascular homeostasis in conjunction with an impaired renal function such as an elevated serum creatinine would reflect renal microvascular disease [5, [13] [14] [15] [16] 
AN INNOVATIVE THERAPEUTIC STRATEGY TO RESTORE RENAL FUNCTION IN DIABETES
Due to the present therapeutic failure in restoring the renal perfusion and function in late diabetic nephropathy, it is obvious that therapeutic strategy for diabetes should be implemented at early stage of renal microvascular disease or early CKD. Treatment at the early stage under which the vascular homeostasis is adequately functional, would assist the vascular response to vasodilator treatment with subsequent vasodilation in the renal microcirculation and thus correction of the renal ischemia. Indeed, vasodilator treatment with vasodilators at early CKD and early diabetic nephropathy during normoalbuminuria in recent studies could enhance renal perfusion, and restore renal function [17, 18] .
